Text of Recommendation | The Under Secretary for Health requires that all community care providers authorized to provide ketamine or esketamine for treatment-resistant depression receive and review VA’s National Protocol Guidance on ketamine infusion and intranasal esketamine. |
---|---|
Recommendation Number | 1 |
Recommendation Status | Closed |
Significant Recommendation | Yes |
Recommendation Questioned Costs | $0 |
Recommendation Funds for Better Use | $0 |
Submitting OIG | |
---|---|
Report Title | Deficiencies in Coordination of Care for Patients with Treatment-Resistant Depression at the VA San Diego Healthcare System in California |
Report Submitting OIG-Specific Report Number | 20-03359-220 |
Report Date Issued | Tuesday, August 24, 2021 |
Report Agency Reviewed / Investigated | |
Report Questioned Costs | $0 |
Report Funds for Better Use | $0 |